Branded

Sandoz is acquiring GSK’s cephalosporin antibiotics business, including three established brands, Zinnat, Zinacef and Fortum.

Libtayo is now approved for both advanced cutaneous squamous cell and basal cell carcinomas.

Upsher-Smith has expanded its Access Pathways Program to offer commercially insured patients a $0 co-pay and free home delivery for acute and preventive migraine treatment options.

ViiV Healthcare’s Cabenuva is the first Food and Drug Administration-approved injectable that is a complete regimen for HIV-infected adults administered once a month.

Merck's Verquvo offers a new treatment option for appropriate patients with symptomatic chronic heart failure.

GSK's Benlysta is now approved for patients with active lupus nephritis.

Agile Therapeutics’ once-weekly Twirla is the first and only contraceptive patch that combines levonorgestrel and ethinyl estradiol.

Merck will acquire Oncolmmune, which recently announced positive findings from a Phase 3 study of its candidate for the treatment of patients with severe and critical COVID-19.